Skip to main content
. 2024 Dec 11;15:1447230. doi: 10.3389/fendo.2024.1447230

Table 3.

Multivariate regression analysis of CMI with testosterone.

Model1 β (95% CI) P value Model2 β (95% CI) P value Model3 β (95% CI) P value
CMI index -33.81 (-37.23, -30.39), <0.001 -32.84 (-36.24, -29.44), <0.001 -6.40 (-8.95, -3.86), <0.001
CMI quartile
Q1 Reference Reference Reference
Q2 -77.54 (-91.1, -63.97), <0.001 -74.02 (-87.52, -60.52), <0.001 -19.91 (-34.38, -5.44), <0.001
Q3 -141.93 (-155.49, -128.36), <0.001 -136.49 (-150.08, -122.90), <0.001 -33.17 (-49.02, -17.32), <0.001
Q4 -197.71 (-211.27, -184.14), <0.001 -192.08 (-205.71, -178.44), <0.001 -45.83 (-64.45, -27.21), <0.001
P for trend <0.001 <0.001 <0.001

Model I: None covariates were adjusted; Model II: age and race were adjusted; Model III: age, race, SBP, DBP, HOMA-IR, HbA1c, E2, SHBG, ALT, AST, serum creatinine, serum uric, albumin, diabetes, moderate physical activities, education level, total energy and total fat intake were adjusted.